Salesforce Inc saw a meaningful market reaction to its fiscal Q2 2027 results on August 26, 2026, jumping about 10.2% in pre-market trade to $226.67. Even with that move, the shares trade at a forward P/E of 14.2x and sit well below their 52-week high of $269.11. With the stock down 22.4% year-to-date entering the report, the recent advance reads more like the start of a recovery than the finish of one - and the company carries a fair-value estimate of $310.79, which the market commentary tied to roughly 37% upside from the post-earnings level.
Earnings and guidance - the beat was large
The company reported what amounted to a blowout quarter across key metrics:
- Adjusted EPS of $5.90 versus a consensus of $3.27 - an approximately 80% beat.
- Revenue of $11.35 billion compared with an $11.32 billion estimate, representing 11% year-over-year growth.
- Free cash flow of $1.1 billion, up 81% year-over-year and nearly double the $643 million Street estimate.
- Full-year EPS guidance was lifted sharply - the outlook moved from $14.06 to $14.12 up to a range of $16.67 to $16.71.
- Agentforce ARR reached $1.5 billion, up 240% year-over-year.
- Claudeforce - a new AI initiative - was announced in partnership with Anthropic to integrate Claude's reasoning into Salesforce workflows.
The company also reported cRPO growth of 14% in constant currency, beating the 13% guidance and marking the firm's first beat of that metric in three quarters. Since cRPO is the forward-looking revenue measure investors often track most closely, that detail carried notable weight.
Valuation and margin expansion
Despite the pop, several valuation and margin metrics show why analysts are reassessing the firm's outlook:
| Metric | Value | Context |
|---|---|---|
| P/E (Forward) | 14.2x | Cheap for enterprise software with 11% revenue growth |
| P/E (LTM) | 21.0x | Compressed by earnings growth outpacing price |
| EV/EBITDA | 14.8x | Below historical averages for CRM |
| FCF Yield | 8.7% | Exceptional cash generation relative to market cap |
| Fair Value | $310.79 | 51.1% upside from Wednesday's close |
| Gross Margin | 77.7% | Expanding for three consecutive years |
| Net Margin | 18.0% | Up from 11.9% two years ago |
Margin expansion is a central theme of the quarter. Gross margins rose to 77.7% from 75.5%, and net margins have nearly doubled over two years - up to 18.0% from 11.9% - indicating operating leverage as revenue growth translates disproportionately to the bottom line.
Technicals - momentum without clear overbought signals
The technical charting backdrop suggests the move still has room to run rather than being exhausted:
- Daily RSI: 62.6 - signaling healthy momentum that is not yet in overbought territory.
- Weekly RSI: 56.9 - a fresh breakout from consolidation as the weekly reading moved above 50.
- Monthly RSI: 46.0 - a neutral signal consistent with a stock recovering from longer-term weakness.
The monthly reading underscores that Salesforce is emerging from a prolonged downtrend - the shares were down 22.4% YTD and 17.8% over one year entering the report - so the latest surge is closing a gap rather than extending an extended rally. Key levels to watch include a weekly pivot at $203.38 that should now act as support, with immediate resistance at $216.85 (weekly R1) and $224.54 (weekly R2). The after-market price of $233.22 was already testing weekly R3 at $238.01.
Analyst reaction - targets move higher
Major brokerages and research firms raised their price targets after the results:
- Citizens - new target $315 - rating Market Outperform
- Jefferies - new $300 from $250 - Buy
- Oppenheimer - new $275 from $250 - Outperform
- Mizuho - new $265 from $250 - Outperform
- BMO Capital - new $260 from $230 - Outperform
- Cantor Fitzgerald - new $250 - Overweight
- Wells Fargo - new $230 from $205 - Equal Weight
Even at the pre-market price of $226.67, five of the seven targets listed are above current levels. The highest target in the group - Citizens at $315 - implies roughly 39% upside from the post-earnings level.
The bull case summarized
Several factors underpin the constructive view:
- AI-driven product momentum - Agentforce ARR reached $1.5 billion with 240% year-over-year growth, and the Claudeforce partnership with Anthropic brings differentiated reasoning capabilities into Salesforce workflows.
- Combined traction - Data 360 and Agentforce combined ARR reached $3.9 billion, up 210% year-over-year, with half of bookings coming from expansions.
- Valuation metrics - trading at 14.2x forward earnings while growing revenue 11% and EPS 33.8% yields a PEG ratio near 0.87, suggesting growth at a discount. The 8.7% FCF yield is notable for a company of this size.
- Re-rating potential - the shares were discounted heading into the report, down 22% YTD and 18% over one year, so the move reflects a shift from priced-in disappointment toward fundamentals.
- Margin durability - three consecutive years of expanding gross margins and rising net margins indicate operating leverage beyond a single quarter.
The bear case and risks
At the same time, several cautions temper the bullish view:
- Beat magnitude has narrowed - Oppenheimer noted the company still beats expectations but by smaller margins for three consecutive quarters.
- Short-term consolidation risk - a 10%+ gap higher frequently invites profit-taking. The monthly chart's Neutral signal means the trend needs verification before declaring a durable reversal.
- Balance sheet leverage - debt-to-equity sits at 124.3%, elevated for a software company. While free cash flow generation mitigates the concern, it remains an item to monitor.
- Competitive and execution risk - competitors including Palantir and specialized AI startups compete for enterprise spend, and the company's government contract pipeline - including a cited $5.6 billion Army deal - carries execution risk.
Practical takeaways - timing matters
For long-term investors, the forward P/E of 14.2x, analyst targets up to $315 and the stated fair-value of $310.79 suggest the shares may still be meaningfully undervalued. A disciplined buy-on-weakness approach - watching for a pullback toward $210 to $215, where prior resistance may become support - was highlighted as a prudent entry.
For traders, the recommendation is to wait for initial volatility to subside. A confirmation would be the stock holding above the $216 weekly R1 level on declining volume, indicating the breakout is genuine and that dips may be buyable. Conversely, a failure to hold the $203 weekly pivot would suggest the post-earnings move is losing traction.
Overall, the fundamental setup - AI-driven ARR growth, accelerating margins, strong free cash flow and raised guidance - appears solid. Whether that translates into further near-term gains depends on an entry price that accounts for expected volatility and the risks outlined above.